“…Drug loading may alter a nanocarrier’s physiochemical properties in a loading-dependent manner, thereby influencing efficacy. For instance, loading of hydrophobic drug molecules within an amphiphilic nanoparticle framework may affect colloidal stability, size, shape, flexibility, internal accessibility, and other parameters, − each of which are important attributes affecting circulation time, clearance, biodistribution, and drug release. − Covalent drug conjugates enable sustained delivery without burst release during circulation, displaying minimized systemic toxicity and increased accumulations in targeted tissue. ,, Furthermore, stimuli-responsive properties provide a preferable spatiotemporal control over payload release, thereby improving therapeutic efficacy while reducing systemic toxicity. ,,,,, Therefore, a thorough knowledge of the role that therapeutics play on the properties of nanomedicines as a function of payload level is of great importance, and control over drug-carrier-media interactions may provide an additional opportunity to tune physicochemical characteristics and biological performance of nanoformulations. As a proof of concept in this study, hydrophobic drugs were conjugated via stimulus-sensitive linkers along the hydrophobic backbone of amphiphilic block copolymers and assembled into nanoscopic micelles to investigate the importance of payload level on stimulus accessibility, drug release, and therapeutic efficacy and selectivity in vitro .…”